Continuous Manufacturing of an AAV-based Gene Therapy

Time: 11:45 am
day: Conference Day 1


• Sharing perfusion process for continuous production of rAAV at high cell density

• Experimentally demonstrated for transient transfection in HEK293 cells

• Presenting good agreement between mechanistic modeling and experimental results

• Demonstrating continuous operations at higher cell densities to increase vector genome titer